Cell-based Therapies Show Promises for Seriously Ill COVID-19 patients

“The US Administration recognizes the lack of reliable and accessible treatments for COVID-19 and the need for investment in the development and manufacturing of therapies, as demonstrated both within the January 21, 2021 Executive Order which outlines policies to accelerate the development of novel therapies to treat COVID-19, and the American Rescue Plan, which formed the basis for the COVID-19 relief package passed by Congress and signed into law by the President in early March 2021.

Congress has authorized nearly $40 billion in funding for vaccines, therapeutics, and other medical supplies within three COVID-19 relief packages—two of which were passed and signed into law in 2020 and one of which was passed and signed into law earlier this year.”


2 views0 comments